About Marion Pharma India Private Limited
Data last updated:
Marion Pharma India Private Limited is a private limited company based in Guwahati, Assam, India. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 10 March 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN U51397AS2004PTC007360. Its GSTIN is 18AADCM9522H1ZB (Assam). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Sushanta Saha and Suparna Saha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at R 2 Second Floor Umang Commercial Complex Paltan Bazar, Guwahati, Assam, India – 781008.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.85 Cr, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹6.95 Lakh (net margin 2.4%) and EBITDA of ₹16.53 Lakh (EBITDA margin 5.8%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 3% over five years.
As per MCA filings, the company has open charges of ₹1.09 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website marionindia.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressR 2 Second Floor Umang Commercial Complex Paltan Bazar, Guwahati, Assam, India – 781008
- IndustryPharma, Animal Pharmaceuticals & Healthcare
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Marion Pharma India Private Limited
The main business activity of Marion Pharma India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Marion Pharma India Private Limited FY 2025 filings available
Marion Pharma India Private Limited reported revenue of ₹2.85 Cr (down 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Marion Pharma India Private Limited
Revenue fell 4% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Marion Pharma India Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹16.53 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹6.95 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Marion Pharma India Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Marion Pharma India are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Marion Pharma India Private Limited
Marion Pharma India Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Animal Pharma). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vet Origin Private Limited | ₹3.13 Cr (FY 2025) | •••• | •••• | 378.0% | •••• | Thiruvananthapuram, Kerala, India |
| Indo Safe Pharma Private Limited | ₹3.12 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Mumbai, Maharashtra, India |
| Brilliant Industries Private Limited | ₹2.99 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Hyderabad, Telangana, India |
| Dishika Biotech Private Limited | ₹2.94 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | Ahmedabad, Gujarat, India |
| Aerovet Life Sciences Private Limited | ₹2.88 Cr (FY 2025) | •••• | •••• | -5.0% | •••• | Lucknow, Uttar Pradesh, India |
| Marion Pharma India Private Limited this company | ₹2.85 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Guwahati, Assam, India |
| Snapan's Pharma Private Limited | ₹2.85 Cr (FY 2024) | •••• | •••• | 129.0% | •••• | Hyderabad, Telangana, India |
| Parvy Pharma Private Limited | ₹2.84 Cr (FY 2024) | •••• | •••• | 7.0% | •••• | Hyderabad, Telangana, India |
| Altar Health Care Private Limited | ₹2.81 Cr (FY 2024) | •••• | •••• | -4.0% | •••• | Delhi, India |
| Amin Impex Private Limited | ₹2.72 Cr (FY 2024) | •••• | •••• | -6.0% | •••• | New Delhi, Delhi, India |
| Supreme Veterinary Chemproducts Private Limited | ₹2.71 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Telangana, India |
Peers are the five companies nearest above and the five nearest below Marion Pharma India by revenue in the Pharma industry (Animal Pharma), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Marion Pharma India Private Limited
Marion Pharma India Private Limited is audited by VISHAL GHEWAR JAIN & CO for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| VISHAL GHEWAR JAIN & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Marion Pharma India Private Limited
Marion Pharma India has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sushanta Saha | Director | 10 Mar 2004 | 22 Years 7 Months | Current |
| Suparna Saha | Director | 03 Sep 2018 | 8 Years 1 Months | Current |
Ownership and Shareholding of Marion Pharma India Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Marion Pharma India Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Dec 2015 | Others | ₹89 Lakh | Open |
| 16 Jan 2014 | United Bank of India | ₹20 Lakh | Open |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Marion Pharma India Private Limited
Employment history and EPFO contributions of people linked to Marion Pharma India.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Marion Pharma India Private Limited
Marion Pharma India Private Limited has 3 board changes on record since 2004: 2 appointments and 1 cessation. The latest: Sujata Saha ceased to be Director on 04 Sep 2018.
Credit Ratings, Litigation & Regulatory Alerts for Marion Pharma India Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Marion Pharma India Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Marion Pharma India Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Marion Pharma India Private Limited
Marion Pharma India has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 18AADCM9522H1ZB | Assam | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Marion Pharma India Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Marion Pharma India Private Limited
Marion Pharma India is an active private limited company based in Guwahati, Assam, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 10 March 2004 (22+ years old) and is registered under CIN U51397AS2004PTC007360.
Marion Pharma India reported revenue of ₹2.85 Cr for FY 2025 (down 4% YoY).
Marion Pharma India has 2 current directors:
- Sushanta Saha - Director
- Suparna Saha - Director
Marion Pharma India reported a net profit of ₹6.95 Lakh (net margin 2.4%) and EBITDA of ₹16.53 Lakh (EBITDA margin 5.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Marion Pharma India is -3% over three years and 3% over five years. In the latest year (FY 2025) revenue fell 4%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Marion Pharma India is 18AADCM9522H1ZB, registered in Assam. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Marion Pharma India is U51397AS2004PTC007360. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Marion Pharma India was incorporated on 10 March 2004, making it 22+ years old. It is registered with the Registrar of Companies, Guwahati.
The peers of Marion Pharma India by revenue are Vet Origin Private Limited, Indo Safe Pharma Private Limited, Brilliant Industries Private Limited, Dishika Biotech Private Limited, Aerovet Life Sciences Private Limited and 5 more, all in the Pharma industry (Animal Pharma).
Sujata Saha ceased to be Director on 04 Sep 2018. Suparna Saha was appointed as Director on 03 Sep 2018. Sushanta Saha was appointed as Director on 10 Mar 2004.
Marion Pharma India can be reached through the website marionindia.com. Its registered office is in Guwahati, Assam, India.